NCT07549308

Brief Summary

This study compares the effects of two calorie-restricted diets-one with whey protein supplementation and one without-and a health education control group on weight and metabolic parameters in overweight and obese individuals, with the aim of informing dietary intervention strategies for this population.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 23, 2024

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

August 8, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 17, 2024

Completed
1.5 years until next milestone

First Posted

Study publicly available on registry

April 24, 2026

Completed
Last Updated

April 24, 2026

Status Verified

April 1, 2026

Enrollment Period

8 months

First QC Date

August 8, 2024

Last Update Submit

April 17, 2026

Conditions

Keywords

Overweight and ObesityWhey ProteinDietary Pattern

Outcome Measures

Primary Outcomes (1)

  • Body weight

    Measured after fasting and voiding, without shoes, in light clothing, using a standard scale

    Baseline; after 4-week intervention; after 8-week intervention;after 12-week intervention

Secondary Outcomes (12)

  • Skeletal muscle mass

    Baseline; after 4-week intervention; after 8-week intervention;after 12-week intervention

  • Body fat mass

    Baseline; after 4-week intervention; after 8-week intervention;after 12-week intervention

  • Body fat percentage

    Baseline; after 4-week intervention; after 8-week intervention;after 12-week intervention

  • Visceral fat area

    Baseline; after 4-week intervention; after 8-week intervention;after 12-week intervention

  • Handgrip strength

    Baseline; after 4-week intervention; after 8-week intervention;after 12-week intervention

  • +7 more secondary outcomes

Study Arms (3)

Whey protein group

EXPERIMENTAL

Participants in the whey protein group underwent a 30% reduction in their average energy intake. They consumed whey protein powder twice daily (13 grams each) with breakfast and afternoon snacks, partially replacing staple foods. The macronutrient distribution for this group was as follows: Carbohydrates: 45%-50% of energy intake Protein: 20%-25% of energy intake Fat: 30% of energy intake The energy-restricted diet lasted for 12 weeks. During this period, clinical nutritionists monitored participants' dietary intake and exercise habits twice a week via WeChat/phone calls. Participants had outpatient visits every 4 weeks for dietary and exercise monitoring and guidance.

Dietary Supplement: whey protein powder

Calorie-restricted balanced diet group

ACTIVE COMPARATOR

Participants in the energy-restricted balanced diet group underwent a 30% reduction in their average energy intake. The macronutrient distribution for this group was as follows: Carbohydrates: 55% of energy intake Protein: 15% of energy intake Fat: 30% of energy intake The energy-restricted diet lasted for 12 weeks. During this period, clinical nutritionists monitored participants' dietary intake and exercise habits twice a week via WeChat/phone calls. Participants had outpatient visits every 4 weeks for dietary and exercise monitoring and guidance.

Behavioral: calorie-restricted balanced diet

Health education control group

ACTIVE COMPARATOR

Participants in the health education control group followed an unrestricted energy healthy diet plan. The macronutrient distribution for this group was as follows: Carbohydrates: 50%-65% of energy intake Protein: 10%-15% of energy intake Fat: 20%-30% of energy intake The intervention lasted for 12 weeks. During this period, clinical nutritionists monitored participants' dietary intake and exercise habits twice a week via WeChat/phone calls. Participants had outpatient visits every 4 weeks for healthy diet and exercise guidance.

Behavioral: health education

Interventions

whey protein powderDIETARY_SUPPLEMENT

The intervention period lasted for 12 weeks. During this time, Participants received dietary guidance from researchers. The whey protein group underwent a 30% energy reduction diet with a macronutrient distribution of 45%-50% carbohydrates, 30% fat, and 20%-25% protein. Participants consumed 13 grams of whey protein powder twice daily, with breakfast and afternoon snacks, partially replacing staple foods.

Whey protein group

The intervention period lasted for 12 weeks. During this time, Participants received dietary guidance from researchers. The calorie-restricted balanced diet group underwent a 30% energy reduction diet with a macronutrient distribution of 55% carbohydrates, 30% fat, and 15% protein.

Calorie-restricted balanced diet group

The intervention period lasted for 12 weeks. During this time, Participants received dietary guidance from researchers. The health education control diet group followed an unrestricted energy healthy diet plan with a macronutrient distribution of 50% -65%carbohydrates, 20%-30% fat, and 10%-15% protein.

Health education control group

Eligibility Criteria

Age25 Years - 35 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 25-35 years old, no gender restrictions
  • Body mass index (BMI) ≥ 24 kg/m²
  • Voluntary consent and signed informed consent form

You may not qualify if:

  • Age \< 25 years or \> 35 years
  • Current use of medications that may affect weight or energy balance (e.g., lipid-lowering drugs, antidiabetic drugs, appetite suppressants), or other protein supplements
  • Presence of acute or chronic viral hepatitis, abnormal liver function (ALT or/and AST \> 3 times the upper limit of normal), kidney disease (serum creatinine \> upper limit of normal), diabetes, malignant tumors, or cardiovascular diseases
  • Gastrointestinal disorders that affect food digestion and absorption (e.g., chronic diarrhea, constipation, severe gastrointestinal inflammation, active peptic ulcer disease, post-gastrointestinal surgery)
  • Psychiatric disorders
  • Allergies to product ingredients or presence of inborn metabolic disorders
  • Pregnancy or lactation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second Affiliated Hospital, Zhejiang University School of Medicine

Hangzhou, Zhejiang, 310009, China

Location

MeSH Terms

Conditions

ObesityOverweight

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 8, 2024

First Posted

April 24, 2026

Study Start

February 23, 2024

Primary Completion

October 17, 2024

Study Completion

October 17, 2024

Last Updated

April 24, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will not share

Locations